Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
March 26, 2021
in
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
The purpose of this study to evaluate the translational application of the safe and effective treatment of Narrow-Band Ultraviolet light B-band (NB-UVB) to high-risk COVID-19 patients in an effort to improve their immune and hemostatic imbalance to increase survival and improve outcomes.
Related posts
Unveiling the Acute Inflammatory Response when Treating COVID with NB-UVB
February 22, 2023
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
BARDA Partners with Cytokind
December 20, 2022
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
Reimagining our Relationship with the Sun with Dr. Richard Weller
November 18, 2022
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
Harnessing Light to Combat Inflammation
November 02, 2022
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
Could the Sun Be Good For Your Heart?
September 25, 2022
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
Cytokind’s Phase 1 Trial Results Published in Experimental Dermatology.
May 31, 2022
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
Dr. Richard Weller Talks About Ultraviolet Light’s Impact on the Body at the Global Dermatology Talks
May 09, 2022
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
Dr. Carmen Castilla Appears on WABC Radios’ Bernie & Sid in the Morning To Discuss Cytokind COVID Trial
September 03, 2021
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
Cytokind, Inc. Announces 1st COVID-19 Patient Enrolled in the Adaptive Photo-Protection Trial
June 10, 2021
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
Cytokind, Inc. Announces Opening of the Adaptive Photo- Protection Clinical Trial for COVID-19 Patients
May 25, 2021
in
Ecosia shows ads in its SERPs, which it calls EcoAds. …
